Issue Information

Abstract

Aims and Scope Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of cutting-edge research from global biomedical researchers across the cancer sciences. The journal considers submissions from all oncologic specialties, including, but not limited to, the following areas: Cancer biology Molecular biology • cellular biology • molecular genetics • genomics • immunology • epigenetics • metabolic studies • proteomics • cytopathology • carcinogenesis • drug discovery and delivery Clinical cancer research Translational research • clinical trials • chemotherapy • radiation therapy • surgical therapy • clinical observations • clinical guidelines • genetic consultation • ethical considerations Cancer prevention Behavioral science • psychosocial studies • screening • nutrition • epidemiology and prevention • community outreach Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper. We aim to be a truly global forum for high-quality cancer research, and we think that the best research should be published and made widely accessible as quickly as possible. Cancer Medicine publishes papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley-Blackwell. Cancer Medicine is a Wiley Open Access journal, one of a new series of peer-reviewed titles publishing quality research with speed and efficiency. For further information visit the Wiley Open Access website at http://www.wileyopenaccess.com. Open Access and Copyright All articles published by Cancer Medicine are fully open access: immediately freely available to read, download and share. All articles accepted from 14 August 2012 are published under the terms of the Creative Commons Attribution License. All articles accepted before this date were published under a Creative Commons Attribution Non-Commercial License. The Creative Commons Attribution License permits use, distribution and reproduction in any medium, provided the original work is properly cited and allows the commercial use of published articles. Copyright on any research article in a journal published by Cancer Medicine is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Further information about open access license and copyright can be found at http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html. Purchasing Print Reprints Print reprints of Wiley Open Access articles can be purchased from [e-mail]. Disclaimer The Publisher and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher and Editors, neither does the publication of advertisements constitute any endorsements by the Publisher and Editors of the products advertised. Wiley Open Access articles posted to repositories or websites are without warranty from Wiley of any kind, either express or implied, including, but not limited to, warranties of merchantability, fitness for a particular purpose, or non-infringement. To the fullest extent permitted by law Wiley disclaims all liability for any loss or damage arising out of, or in connection with, the use of or inability to use the content. Editor-in-Chief Qingyi Wei, M.D., Ph.D. The University of Texas MD Anderson Cancer Center, Houston, USA Editorial Board Cancer Biology Richard J. Ablin University of Arizona College of Medicine, Tucson, USA Rosalind Eeles Institute of Cancer Research, Sutton, UK Elizabeth A. Grimm The University of Texas MD Anderson Cancer Center, Houston, USA Giseli Klassen Federal University of Parana, Curitiba, Brazil Gang Li University of British Columbia, Vancouver, Canada Youyong Lu Beijing Institute for Cancer Research, Beijing, China Kenneth Offit Memorial Sloan-Kettering Cancer Center, New York, USA Athanasios G. Papavassiliou University of Athens Medical School, Athens, Greece Kenneth Pienta University of Michigan, An Arbor, USA Jack A. Schalken Radboud University Medical Centre, Nijmegen, Netherlands Kazu Ushijima National Cancer Center, Tokyo, Japan David Vaux Walter and Eliza Hall Institute of Medical Research, Parkville, Australia Cun-Yu Wang UCLA School of Dentistry, Los Angeles, USA Hongyang Wang Eastern Hepatobiliary Surgery Institute / Hospital, Shanghai, China Momiao Xiong The University of Texas Health Science Center, Houston, USA Li Zhang The University of Texas MD Anderson Cancer Center, Houston, USA Clinical Cancer Research Yung-Jue Bang Seoul National University College of Medicine, Seoul, Korea Anthony Chan The Chinese University of Hong Kong, China Jiuwei Cui The First Hospital of Jilin University, Jilin, China Peter J. Fuller Prince Henry Institute, Victoria, Australia Maura L. Gillison Ohio State University Comprehensive Cancer Center, Columbus, USA Guido Kroemer University of Paris Descartes, Paris, France Lalit Kumar All India Institute of Medical Sciences, New Delhi, India Razelle Kurzrock The University of Texas MD Anderson Cancer Center, Houston, USA Geoffrey Liu Princess Margaret Hospital, Toronto, Canada Jiade J. Lu National University of Singapore, Singapore Li Mao University of Maryland, Baltimore, USA Akira Nakagawara Chiba University, Chiba, Japan Pamela L. Paris University of California, San Francisco, USA Dimitrios H. Roukos Ioannina University School of Medicine, Ioannina, Greece Frank A. Sinicrope Mayo clinic, Rochester, USA Jun Wang BGI-Shenzhen, Shenzhen, China Glen J. Weiss Translational Genomics Research Institute, Phoenix, USA Senming Wang Southern Medical University, Guangzhou, China Eric T. Wong Beth Israel Deaconess Medical Center, Boston, USA Xianglin Yuan Huazhong University of Science and Technology, Wuhan, China Cancer Prevention Marianne Berwick University of New Mexico, Albuquerque, USA Paolo Boffetta The Tisch Cancer Institute, New York, USA Eduardo Cazap Latin-American & Caribbean Society of Medical Oncology, Buenos Aires, Argentina Brock C. Christensen Dartmouth Medical School, Hanover, USA Steve Dubinett David Geffen School of Medicine at UCLA, Los Angeles, USA Kari Hemminki German Cancer Research Center, Heidelberg, Germany Zhibin Hu Nanjing Medical University, Nanjing, China Stephen D. Hursting The University of Texas, Austin, USA Daehee Kang Seoul National University College of Medicine, Seoul, Republic of Korea Lambertus A. Kiemeney Radboud University Medical Centre, Nijmegen, Netherlands Donghui Li The University of Texas MD Anderson Cancer Center, Houston, USA Dongxin Lin Chinese Academy of Medical Sciences, Beijing, China Somdat Mahabir National Cancer Institute, Bethesda, USA Girish Maru ACTREC Tata Memorial Centre, Navi Mumbai, India Andrew Olshan University of North Carolina, Chapel Hill, USA Jong Y. Park H. Lee Moffi tt Cancer Center & Research Institute, Tampa, USA Susan K. Peterson The University of Texas MD Anderson Cancer Center, Houston, USA Thomas E. Rohan Albert Einstein College of Medicine, Bronx, USA Xifeng Wu The University of Texas MD Anderson Cancer Center, Houston, USA Editorial Advisory Board Lawrence Baker University of Michigan, Ann Arbor, USA David Christiani Harvard School of Public Health, Boston, USA Robert B. Diasio Mayo Clinic, Rochester, USA B. Mark Evers Lucille P. Markey Cancer Center, Lexington, USA Waun Ki Hong The Univeristy of Texas MD Anderson Cancer Center, Houston, USA Ernest Hawk The University of Texas MD Anderson Cancer Center, Houston, USA Leroy Hood Institute for Systems Biology, Seattle, USA James Mulé H. Lee Moffi tt Cancer Center & Research Institute, Tampa, USA Philip Agop Philip Wayne State University, Detroit, USA Nicholas Vogelzang Comprehensive Cancer Centers of Nevada, Vegas, USA